0001533635-20-000001.txt : 20200212 0001533635-20-000001.hdr.sgml : 20200212 20200211190930 ACCESSION NUMBER: 0001533635-20-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200212 DATE AS OF CHANGE: 20200211 EFFECTIVENESS DATE: 20200212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tempest Therapeutics, Inc. CENTRAL INDEX KEY: 0001533635 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-306741 FILM NUMBER: 20598740 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3690 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 415-798-8589 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3690 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 FORMER COMPANY: FORMER CONFORMED NAME: Inception 2, Inc. DATE OF NAME CHANGE: 20111027 D/A 1 primary_doc.xml X0708 D/A LIVE 0001533635 Tempest Therapeutics, Inc. 7000 Shoreline Court SUITE 275 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 (415) 798-8589 DELAWARE Next Beta, Inc. Inception 2, Inc. Corporation true Thomas W. Dubensky, Jr. c/o Tempest Therapeutics, Inc. 7000 Shoreline Court, Suite 275 South San Francisco CA CALIFORNIA 94080 Executive Officer Director Paul Grayson One Sansome Street Suite 3630 San Francisco CA CALIFORNIA 94104 Director Petpiboon Prasit c/o Tempest Therapeutics, Inc. 7000 Shoreline Court, Suite 275 South San Francisco CA CALIFORNIA 94080 Director Thomas Woiwode One Sansome Street Suite 3630 San Francisco CA CALIFORNIA 94104 Director Stella Xu 4560 Jinke Rd., Bldg. 1N, Suite 401 Zhangjiang Hi-tech Park, Pudong New Area Shanghai F4 CHINA 201210 Director Robert Weisskoff c/o F-Prime Capital Partners One Main Street, 13th Floor Cambridge MA MASSACHUSETTS 02142 Director Michael Raab c/o Ardelyx, Inc. 34175 Ardenwood Blvd, Suite 200 Fremont CA CALIFORNIA 94555 Director Keting Chu 1209 Orange Street Wilmington DE DELAWARE 19801 Director Other Health Care Decline to Disclose 06b true 0001533635-19-000001 2018-02-16 false true false 1 100186733 83186733 17000000 false 10 0 0 0 false Tempest Therapeutics, Inc. /s/ Thomas W. Dubensky, Jr. Thomas W. Dubensky, Jr. President and Chief Executive Officer 2020-02-11